SpyGlass Pharma
PublicSpyGlass Pharma is now publicly traded
The data on this page reflects SpyGlass Pharma's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Feb 9, 2026
Last Round
Series D
Jun 2, 2025
Est. Valuation at Exit
$355M
Total Funding Raised
$371M
Company Overview
SpyGlass Pharma is a biopharmaceutical company that develops sustained drug delivery systems for the treatment of chronic ophthalmic conditions.
Sector
Healthcare/Wellness
Verticals
HealthTech, Life Sciences
AI Layer
Non-AI
Keywords
SpyGlass Pharma Comparables
Compare SpyGlass Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glaukos Corporation | 85% | |
| PolyActiva | 78% | |
| Ocular Therapeutix Inc | 78% |
SpyGlass Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Feb 9, 2026 | ||||
| Series D | Jun 2, 2025 | ||||
| Series C | Jul 10, 2023 | ||||
| Series B | Jan 7, 2021 | ||||
| Series A | May 1, 2019 |
Key People
Founding team and executive leadership
SpyGlass Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| RA Capital Advisors | Series C, Series D |
| RA Capital Management | IPO, Series D, Series C |
| Vertex Ventures HC | IPO, Series C, Series D |
| New Enterprise Associates (NEA) | Series B, IPO, Series D, Series C, Series A |
| Gilde Healthcare | IPO, Series D |
| Vensana Capital | IPO, Series C, Series B, Series D |
Recent news
Latest coverage and updates
- expands_offices_inAug 27, 2026
SpyGlass Pharma, Inc. expanded offices in Irvine, California, United States, Northern America, Americas on Feb 1st '26.
- expands_facilitiesAug 27, 2026
SpyGlass Pharma, Inc. expanded facilities to Irvine, California, United States, Northern America, Americas on Aug 27th '26.
- expands_offices_toAug 27, 2026
SpyGlass Pharma, Inc. expanded offices to Irvine, California, United States, Northern America, Americas on Aug 27th '26.
- expands_offices_toAug 27, 2026
SpyGlass Pharma, Inc. expanded offices to Irvine, California, United States, Northern America, Americas on Feb 1st '26.
- expands_facilitiesAug 27, 2026
SpyGlass Pharma, Inc. expanded facilities to Aliso Viejo, California, United States, Northern America, Americas on Jul 1st '21.
SpyGlass Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access